|
|
|
|
|
|
||||||||
|
||||||||
![]() Click here for low bandwidth version |
USD
USD
|
EUR
EUR
|
GBP
GBP
|
Converter
Converter
|
||
|
|
|||||
Gold (INR/Gram)
Gold (INR/Gram)
|
Silver (INR/Kilo)
Silver (INR/Kilo)
|
||||
| LIVE DATA TERMINALS: Nifty50 | IT | Bank | |
|
|
Aventis Pharmaceuticals | Aventis Pharmaceuticals Limited | Live NSE Share Price Quotes Aventis Pharmaceuticals | Realtime Aventis Pharmaceuticals Chart |
| LIVE QUOTES - LIST OF ALL NSE STOCKS WITH CURRENT PRICES |
|
more information on Aventis Pharmaceuticals Limited from bse
|
|||||||||||||||||||||||||
Aventis Pharmaceuticals Limited - 3 Months Candlestick Chart |
|
AVENTIS PHARMA LIMITED : renamed 'Sanofi India Limited'
AVENTIS PHARMA LIMITED : renamed 'Sanofi India Limited'
4-traders - May 17, 2012 Mumbai, May 16, 2012: Sanofi Group's listed entity in India today announced that the Registrar of Companies had approved Company's change of name from Aventis Pharma Limited to 'Sanofi India Limited', with effect from May 11, 2012.
Quick view : Videocon Industries net down 70% at R50.32 cr
Quick view : Videocon Industries net down 70% at R50.32 cr
Financial Express - May 16, 2012 Diversified business group Videocon Industries on Wednesday reported 69.81% dip in standalone net profit at R50.32 crore for the quarter ended March.
Aventis Pharma Limited renamed 'Sanofi India Limited'
Aventis Pharma Limited renamed 'Sanofi India Limited'
pharmabiz.com - May 16, 2012 Sanofi Group's listed entity in India has announced that the Registrar of Companies had approved company's change of name from Aventis Pharma Limited to 'Sanofi India Limited', with effect from May 11, 2012.
Aventis Pharma - Change of name of the Company - Moneycontrol.com
Section27, TAC join big pharma bust-up over cancer drug
Section27, TAC join big pharma bust-up over cancer drug
Mail & Guardian Online - May 16, 2012 The TAC and Section 27 have joined the fray in a face-off between Aventis Pharma and Cipla Life Sciences in a patent war over cancer drug Docetaxel.
|
|
About Indiansplash.com |
Disclaimer |
Privacy Policy |
Terms of Use |
Advertise |
Sitemap |
Contact Us
|